Results 121 to 130 of about 15,511 (169)

Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]

BMJ Open
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc   +1 more source

Type I and II Interferons Drive Abacavir Hypersensitivity via Treg Suppression and T-Cell Enhancement in Immunocompetent HLA-Transgenic Mice. [PDF]

Allergy
Hwang S, Sepahpour T, Kortchak S, Sivakumar KK, Karaiskos S, Pham N, Jang Y, Puig M, Norcross M.   +8 more
europepmc   +1 more source

Contemporary Single and Multi-Tablet HIV Treatment Regimens Are Associated With Similar Levels of Viral Suppression. [PDF]

Open Forum Infect Dis
Yao K, Lawson L, Pistoresi R, Sullivan D, Golden MR.   +4 more
europepmc   +1 more source

Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials. [PDF]

Open Forum Infect Dis
Post FA, Wohl D, Liegeon G, Brar I, Hagins D, Yazdanpanah Y, Avihingsanon A, Liu H, Aizen K, Hindman JT, Gupta S.   +10 more
europepmc   +1 more source

Regional Variations of Rates and Determinants of Drug Resistance Mutations in People Failing First-line Therapy for HIV-1: A Substudy from the D2EFT Phase 3b/4 Clinical Trial. [PDF]

Clin Infect Dis
Obeng BM, Hutchinson J, Shaik A, Chetchotisakd P, Azwa I, Wulan WN, Kumarasamy N, Wolff M, Bruguera J, Losso M, Kaplan R, Diallo MS, Eriobu N, Musoro G, Kumalawati J, Badamasi A, Fitriah M, Mulya DP, Law M, Matthews G, Di Giallonardo F, Kelleher AD, Dolutegravir and Darunavir Evaluation in Adults Failing Therapy (D2EFT) Study Group.   +22 more
europepmc   +1 more source

Antiretroviral therapy switch among Medicare beneficiaries with HIV. [PDF]

J Manag Care Spec Pharm
Christoph MJ, Mordi U, Li S, Guo H, Gong T, Lim T, Park S, Zachry W, Tien PC.   +8 more
europepmc   +1 more source

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Gurney J, Gandhi-Patel B, Unger N, Mordi U, Chen M, Jarrett J, Sherman EM, Mounzer K, Khalsa AM, Dinges WL, McKellar MS, Lipps A.   +17 more
europepmc   +1 more source

The Expanding Role of Companion Diagnostics in Infectious Diseases: Lessons From Abacavir and Human Immunodeficiency Virus Care

iLABMED
Yi‐Wei Tang, Eric vonHofe
doaj   +1 more source

Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV. [PDF]

Antimicrob Agents Chemother
van Dyk J, Waitt C, Mugerwa H, Wiesner L, Orrell C, Bamford A, Gibb DM, McIlleron HM, Colbers A, Burger DM, Denti P, Wasmann RE.   +11 more
europepmc   +1 more source

Major ECG abnormalities and risk of incident cardiovascular disease in people with HIV compared to people without HIV. [PDF]

AIDS
Vanbellinghen MC, van der Wulp IAJ, Postema PG, Kors JA, van der Loeff MFS, Reiss P, van der Valk M, Boyd A.   +7 more
europepmc   +1 more source